Dietary phosphate modulates atherogenesis and insulin resistance in apolipoprotein e knockout mice-brief report

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 9, 2011, Pages 1988-1990

  Ellam, Timothy ^a   Wilkie, Martin ^b   Chamberlain, Janet ^c   Crossman, David ^a   Eastell, Richard ^a   Francis, Sheila ^c   Chico, Timothy J A ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b Sheffield Kidney Institute   (United Kingdom)

^c NONE

Author keywords

atherosclerosis; fibroblast growth factor 23; insulin resistance; phosphate; prevention

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN E; FIBROBLAST GROWTH FACTOR 23; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA SINUS; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; BLOOD CHEMISTRY; BLOOD PRESSURE; CONTROLLED STUDY; EPIDIDYMIS FAT; FATTY LIVER; HOMEOSTASIS; HOMEOSTATIC MODEL ASSESSMENT; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; OBESITY; PHOSPHATE BLOOD LEVEL; PHOSPHATE INTAKE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPOSITY; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; FATTY LIVER; INSULIN RESISTANCE; MALE; MICE; MICE, KNOCKOUT; PHOSPHATES;

EID: 80052141099     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.231001     Document Type: Article

References (9)

1. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007;167:879-885. (Pubitemid 46762749)
2. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112:2627-2633. (Pubitemid 41532599)
3. Narang R, Ridout D, Nonis C, Kooner JS. Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol. 1997;60:73-79. (Pubitemid 27288259)
4. Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol. 2009;20:397-404.
5. Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M, Shlipak MG, Whooley MA, Ix JH. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med. 2010;152:640-648.
6. Park W, Kim BS, Lee JE, Huh JK, Kim BJ, Sung KC, Kang JH, Lee MH, Park JR, Rhee EJ, Oh KW, Lee WY, Park CY, Park SW, Kim SW. Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: a double-edged sword. Diabetes Res Clin Pract. 2009;83: 119-125.
7. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol.
8. Shuto E, Taketani Y, Tanaka R, Harada N, Isshiki M, Sato M, Nashiki K, Amo K, Yamamoto H, Higashi Y, Nakaya Y, Takeda E. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol. 2009;20: 1504-1512.
9. Xie W, Tran TL, Finegood DT, van de Werve G. Dietary P(i) deprivation in rats affects liver cAMP, glycogen, key steps of gluconeogenesis and glucose production. Biochem J. 2000;352:227-232.